Home Knowledge, attitude, and practice of pharmacists towards management of hypertension in primary care centers
Article
Licensed
Unlicensed Requires Authentication

Knowledge, attitude, and practice of pharmacists towards management of hypertension in primary care centers

  • I Nyoman Wijaya EMAIL logo , Umi Athiyah , Fasich and Andi Hermansyah ORCID logo
Published/Copyright: January 11, 2020
Journal of Basic and Clinical Physiology and Pharmacology
From the journal Journal of Basic and Clinical Physiology and Pharmacology Volume 30 Issue 6

Abstract

Background

Hypertension is one of the major health problems of the world and one of the most important causes of death in Indonesia. Complication due to hypertension leads to myocardial infarction, stroke, and renal failure. Pharmacist in primary care centers (Puskesmas) plays an important role in the management of hypertension. The purpose of this study was to assess the knowledge, attitude, and practice (KAP) of pharmacists working in Puskesmas in Surabaya, Indonesia, towards the management of hypertension.

Methods

A cross-sectional survey was conducted from March to July 2019 in 63 Puskesmas in Surabaya. A questionnaire was developed from the literature to assess KAP and administered to the pharmacists. Data was analyzed using SPSS version-17 and presented in terms of descriptive variables. The mean age of the participants was 34.6 ± 4.9 years (24–45 years old), and 82.5% were females. Majority of the respondents (74.6%) had more than 5 years of experience in Puskesmas.

Results

Overall, pharmacists had moderate knowledge, and the majority had good attitude and showed satisfactory practice in the management of hypertension.

Conclusions

There is still a need for continuing education, workshops, and seminars for pharmacists in order to maintain their performance.

Keywords: attitude; hypertension; knowledge; management; practice

Acknowledgments

The authors thank the Surabaya city health office for collaborating and providing access to this research. They also thank the participating pharmacists for sparing their time and effort for this study.

  1. Research funding: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: Ethical approval for this study was obtained from the Faculty of Public Health Airlangga University Ethical Committee (Ethical Approval No.200/EA/KEPK/2019).

References

[1] Cipolle JR, Strand ML, Morley CP. Pharmaceutical care practice: the patient-centered approach to medication management services, 3rd ed. New York, NY: McGraw-Hills, Inc., 2012.Search in Google Scholar

[2] Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47:533–43.10.1093/ajhp/47.3.533Search in Google Scholar

[3] Ministry of Health of the Republic of Indonesia. Regulation of the Minister of Health of the Republic of Indonesia Number 74 Year 2016 Concerning Pharmaceutical Service Standards in Puskesmas, Ministry of Health of the Republic of Indonesia, Jakarta, 2016.Search in Google Scholar

[4] Ministry of Health Republic of Indonesia. Pharmaceutical Care for Hypertension. Jakarta: Directorate of Community and Clinical Pharmacy Development, Director General of Pharmaceutical and Medical Devices Development, Ministry of Health of the Republic of Indonesia, Jakarta, 2006.Search in Google Scholar

[5] Health Research and Development Agency Ministry of Health Ministry of Health Republic of Indonesia. National Health Research 2013. Jakarta, 2013.Search in Google Scholar

[6] Surabaya City Health Department. Profile of Surabaya City Health Office. Surabaya, Indonesia: Health Department of Surabaya, 2015.Search in Google Scholar

[7] Campbell Norm Norm RC, Lackland Daniel T, Niebylski Mark L. The World Hypertension League and International Society of Hypertension Executive Committees. High Blood Pressure: Why Prevention and Control Are Urgent and Important-A 2014 Fact Sheet From the World Hypertension League and the International Society of Hypertension. The Journal of Clinical Hypertension 2014;16(8):551–553. DOI: 10.1111/jch.12372.Search in Google Scholar PubMed PubMed Central

[8] WHO. A global brief on hypertension silent killer, global public health crisis. New York, NY: WHO, 2013.Search in Google Scholar

[9] Dipiro TJ, Talbert LR, Yee CG, Matzke RG, Wells GB, Posey ML. Hypertension, pharmacotherapy: a pathophysiologic approach, 7th ed. New York, NY: McGraw-Hill Companies, Inc., 2012.Search in Google Scholar

[10] Ministry of Health of the Republic of Indonesia. Regulation of the Minister of Health of the Republic of Indonesia Number 75 of 2014 Concerning Community Health Centers, Ministry of Health of the Republic of Indonesia, Jakarta, 2014.Search in Google Scholar

[11] Abah IO, Dare BM, Jimoh HO. Hypertension prevalence, knowledge, attitude and awareness among pharmacists in Jos, Nigeria. West African J Pharm 2014;25:98–106.Search in Google Scholar

[12] Athiyah Umi, Setiawan Catur D., Nugaheni Gesnita, Zairina Elida, Utami Wahyu, Hermansya Andi, Assessment of pharmacists’ knowledge, attitude and practice in chain community pharmacies towards their current function and performance in Indonesia. Pharmacy Practice. 2019;17(3):1518–1518. DOI: 10.18549/pharmpract.2019.3.1518 .Search in Google Scholar

[13] Ebid A-H, Ali ZT, Ghobary MA. Blood pressure control in hypertensive patients: impact of an Egyptian pharmaceutical care model. J Appl Pharm Sci 2014;4:93–101.Search in Google Scholar

[14] Cutler Rachelle Louise, Torres-Robles Andrea, Wiecek Elyssa, Drake Barry, Van der Linden Naomi, Benrimoj Shalom I (Charlie), Garcia-Cardenas Victoria, Pharmacist-led medication non-adherence intervention: reducing the economic burden placed on the Australian health care system. Patient Preference and Adherence 2019;13:853–862. DOI: 10.2147/PPA.S191482.Search in Google Scholar PubMed PubMed Central

[15] JNC-8 (The Eighth Joint National Committee). Evidence-based guideline for the management of high blood pressure in adults. Guideline for management of high blood pressure. American Medical Association, 2014.Search in Google Scholar

[16] Al-Tameemi Noor Noor Kifah, Sarriff Azmi. Knowledge, attitude and practice of pharmacists on medication therapy management: a survey in Hospital Pulau Pinang, Penang, Malaysia. Journal of Pharmaceutical Health Care and Sciences. 2019;5(1). DOI: 10.1186/s40780-019-0131-9.Search in Google Scholar PubMed PubMed Central

[17] Rosenthal M, Holmes E, Banahan II. Making MTM implementable and sustainable in community pharmacy: is it time for a different game plan? Res Social Adm Pharm 2016;12:523–8.10.1016/j.sapharm.2015.07.006Search in Google Scholar PubMed

[18] Directorate of Community Pharmacy and Clinic Development Directorate General of Pharmaceutical and Medical Devices Development. Pharmaceutical care for hypertension. Ministry of Health 2006. Director of Community Pharmacy and Clinical Development, Jakarta, December 2006.Search in Google Scholar

[19] Hermansyah Andi, Sainsbury Erica, Krass Ines. Investigating the impact of the universal healthcare coverage programme on community pharmacy practice. Health & Social Care in the Community. 2017;26(2):e249–e260. DOI: 10.1111/hsc.12506.Search in Google Scholar PubMed

Received: 2019-10-29
Accepted: 2019-11-06
Published Online: 2020-01-11

© 2019 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Reviews
  2. Pharmacist contributions in the treatment of diabetes mellitus in Southeast Asia: a narrative review
  3. The implementation of a chronic disease management program (Prolanis) in Indonesia: a literature review
  4. Original Articles
  5. Quercetin attenuates acute predator stress exposure-evoked innate fear and behavioral perturbation
  6. Evaluating current practices and policies in the use of injectable medicines for treating myalgia in a primary care center in Pamekasan, Indonesia
  7. The contemporary role and potential of pharmacist contribution for community health using social media
  8. Evaluation of rational drug use based on World Health Organization prescribing indicators in a primary care center in Pamekasan East Java, Indonesia
  9. The prescription patterns of second-generation antipsychotics in schizophrenia outpatient setting
  10. Factors affecting community pharmacist’s service for women with chronic diseases during pregnancy and breastfeeding: application of the Health Belief Model
  11. Overview of therapeutic changes in antiepileptic drugs in adult patients
  12. Exploration of barriers affecting job satisfaction among community pharmacists
  13. Patients’ characteristics and their adherence to insulin therapy
  14. Correlation of chemotherapy costs with quality of life in nasopharyngeal cancer patients
  15. Impact of educational preeclampsia prevention booklet on knowledge and adherence to low dose aspirin among pregnant women with high risk for preeclampsia
  16. Translation, cultural adaptation, and validation of the quality of well being self-administered questionnaire in general population in Indonesia
  17. Knowledge, attitude, and practice of pharmacists towards management of hypertension in primary care centers
  18. Medication adherence in diabetes mellitus patients at Tanjung Karang Primary Health Care Center, Mataram
  19. Decreasing angiogenesis vasa vasorum through Lp-PLA2 and H2O2 inhibition by PSP from Ganoderma lucidum in atherosclerosis: in vivo diabetes mellitus type 2
  20. Antiaggregation effect of clopidogrel in coronary heart disease patients using omeprazole
  21. The effect of curcuma (Curcuma xanthorrizha roxb.) extract as an adjuvant of captopril therapy on cardiac histopathology of male mice (Mus musculus) with hypertension
  22. Coenzyme Q10 nanostructured lipid carriers as an inducer of the skin fibroblast cell and its irritability test in a mice model
  23. Medical problems in patients with chronic kidney disease undergoing hemodialysis and their therapy
  24. ADMET properties of novel 5-O-benzoylpinostrobin derivatives
  25. Development of nonalcoholic fatty liver disease model by high-fat diet in rats
  26. Molecular docking of novel 5-O-benzoylpinostrobin derivatives as wild type and L858R/T790M/V948R mutant EGFR inhibitor
  27. The relationship between the level of education and accuracy of insulin injection techniques in DM patients with measurement of HbA1c values
  28. The effect of premixed insulin to blood glucose concentration in patients with type 2 diabetes mellitus
  29. Intravenous insulin therapy in diabetes mellitus with hyperglycemic crisis and intercurrent illness
  30. Adherence behavior assessment of oral antidiabetic medication use: a study of patient decisions in long-term disease management in primary health care centers in Surabaya
  31. Evaluation to the chemotherapy use in patients with diffuse large B-cell lymphoma
  32. Analysis of the use and cost of stress ulcer prophylaxis for surgical inpatients
  33. Antineuroinflammation activity of n-butanol fraction of Marsilea crenata Presl. in microglia HMC3 cell line
  34. The enhancement of Arg1 and activated ERβ expression in microglia HMC3 by induction of 96% ethanol extract of Marsilea crenata Presl. leaves
  35. Ternary solid dispersion to improve solubility and dissolution of meloxicam
  36. Improving solubility and dissolution of meloxicam by solid dispersion using hydroxypropyl methylcellulose 2910 3 cps and nicotinamide
  37. o-Hydroxycinnamic derivatives as prospective anti-platelet candidates: in silico pharmacokinetic screening and evaluation of their binding sites on COX-1 and P2Y12 receptors
  38. The change of proinflammatory cytokine tumor necrosis factor α level in the use of meloxicam in rat model of osteoarthritis
  39. Attenuation of IL-1ß on the use of glucosamine as an adjuvant in meloxicam treatment in rat models with osteoarthritis
  40. Analysis of effectiveness and drug related problems of pain reliever for knee osteoarthritis: weighing clinical risk and benefit
  41. Comparison of antibiotic prescriptions in adults and children with upper respiratory tract infections in Bangka Tengah primary health care centers
  42. Profile of sociodemographics, sources of infection, antiretrovirals and CD4 counts on HIV/AIDS outpatients in Turen Primary Health Centre, Indonesia
  43. Synergistic anti-hepatitis C virus activity of Ruta angustifolia extract with NS3 protein inhibitor
  44. In vitro equivalence of generic and branded amoxicillin tablet by microbiological assay method
  45. Knowledge and attitude: two fundamental factors that determine patient compliance in antibiotic therapy
  46. Molecular docking study of sappan wood extract to inhibit PBP2A enzyme on methicillin-resistant Staphylococcus aureus (MRSA)
  47. Effect of curcumin analogue synthetic product from cullilawan oil for the liver damage treatment in male mice (Mus musculus L.)
  48. Case Report
  49. A case report of generalized tetanus in a 42-year-old man with dental infection
https://doi.org/10.1515/jbcpp-2019-0319
Keywords for this article
attitude; hypertension; knowledge; management; practice

Articles in the same Issue

  1. Reviews
  2. Pharmacist contributions in the treatment of diabetes mellitus in Southeast Asia: a narrative review
  3. The implementation of a chronic disease management program (Prolanis) in Indonesia: a literature review
  4. Original Articles
  5. Quercetin attenuates acute predator stress exposure-evoked innate fear and behavioral perturbation
  6. Evaluating current practices and policies in the use of injectable medicines for treating myalgia in a primary care center in Pamekasan, Indonesia
  7. The contemporary role and potential of pharmacist contribution for community health using social media
  8. Evaluation of rational drug use based on World Health Organization prescribing indicators in a primary care center in Pamekasan East Java, Indonesia
  9. The prescription patterns of second-generation antipsychotics in schizophrenia outpatient setting
  10. Factors affecting community pharmacist’s service for women with chronic diseases during pregnancy and breastfeeding: application of the Health Belief Model
  11. Overview of therapeutic changes in antiepileptic drugs in adult patients
  12. Exploration of barriers affecting job satisfaction among community pharmacists
  13. Patients’ characteristics and their adherence to insulin therapy
  14. Correlation of chemotherapy costs with quality of life in nasopharyngeal cancer patients
  15. Impact of educational preeclampsia prevention booklet on knowledge and adherence to low dose aspirin among pregnant women with high risk for preeclampsia
  16. Translation, cultural adaptation, and validation of the quality of well being self-administered questionnaire in general population in Indonesia
  17. Knowledge, attitude, and practice of pharmacists towards management of hypertension in primary care centers
  18. Medication adherence in diabetes mellitus patients at Tanjung Karang Primary Health Care Center, Mataram
  19. Decreasing angiogenesis vasa vasorum through Lp-PLA2 and H2O2 inhibition by PSP from Ganoderma lucidum in atherosclerosis: in vivo diabetes mellitus type 2
  20. Antiaggregation effect of clopidogrel in coronary heart disease patients using omeprazole
  21. The effect of curcuma (Curcuma xanthorrizha roxb.) extract as an adjuvant of captopril therapy on cardiac histopathology of male mice (Mus musculus) with hypertension
  22. Coenzyme Q10 nanostructured lipid carriers as an inducer of the skin fibroblast cell and its irritability test in a mice model
  23. Medical problems in patients with chronic kidney disease undergoing hemodialysis and their therapy
  24. ADMET properties of novel 5-O-benzoylpinostrobin derivatives
  25. Development of nonalcoholic fatty liver disease model by high-fat diet in rats
  26. Molecular docking of novel 5-O-benzoylpinostrobin derivatives as wild type and L858R/T790M/V948R mutant EGFR inhibitor
  27. The relationship between the level of education and accuracy of insulin injection techniques in DM patients with measurement of HbA1c values
  28. The effect of premixed insulin to blood glucose concentration in patients with type 2 diabetes mellitus
  29. Intravenous insulin therapy in diabetes mellitus with hyperglycemic crisis and intercurrent illness
  30. Adherence behavior assessment of oral antidiabetic medication use: a study of patient decisions in long-term disease management in primary health care centers in Surabaya
  31. Evaluation to the chemotherapy use in patients with diffuse large B-cell lymphoma
  32. Analysis of the use and cost of stress ulcer prophylaxis for surgical inpatients
  33. Antineuroinflammation activity of n-butanol fraction of Marsilea crenata Presl. in microglia HMC3 cell line
  34. The enhancement of Arg1 and activated ERβ expression in microglia HMC3 by induction of 96% ethanol extract of Marsilea crenata Presl. leaves
  35. Ternary solid dispersion to improve solubility and dissolution of meloxicam
  36. Improving solubility and dissolution of meloxicam by solid dispersion using hydroxypropyl methylcellulose 2910 3 cps and nicotinamide
  37. o-Hydroxycinnamic derivatives as prospective anti-platelet candidates: in silico pharmacokinetic screening and evaluation of their binding sites on COX-1 and P2Y12 receptors
  38. The change of proinflammatory cytokine tumor necrosis factor α level in the use of meloxicam in rat model of osteoarthritis
  39. Attenuation of IL-1ß on the use of glucosamine as an adjuvant in meloxicam treatment in rat models with osteoarthritis
  40. Analysis of effectiveness and drug related problems of pain reliever for knee osteoarthritis: weighing clinical risk and benefit
  41. Comparison of antibiotic prescriptions in adults and children with upper respiratory tract infections in Bangka Tengah primary health care centers
  42. Profile of sociodemographics, sources of infection, antiretrovirals and CD4 counts on HIV/AIDS outpatients in Turen Primary Health Centre, Indonesia
  43. Synergistic anti-hepatitis C virus activity of Ruta angustifolia extract with NS3 protein inhibitor
  44. In vitro equivalence of generic and branded amoxicillin tablet by microbiological assay method
  45. Knowledge and attitude: two fundamental factors that determine patient compliance in antibiotic therapy
  46. Molecular docking study of sappan wood extract to inhibit PBP2A enzyme on methicillin-resistant Staphylococcus aureus (MRSA)
  47. Effect of curcumin analogue synthetic product from cullilawan oil for the liver damage treatment in male mice (Mus musculus L.)
  48. Case Report
  49. A case report of generalized tetanus in a 42-year-old man with dental infection
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Have an idea on how to improve our website?
Please write us.
© 2025 De Gruyter Brill
Downloaded on 13.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jbcpp-2019-0319/html
Scroll to top button